HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
HemoGenyx Pharmaceuticals Cash from Operations (Annual) : -4.543M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -4.543M |
| December 31, 2024 | -5.261M |
| December 31, 2023 | -7.484M |
| December 31, 2022 | -3.561M |
| December 31, 2021 | -3.589M |
| Date | Value |
|---|---|
| December 31, 2020 | -2.589M |
| December 31, 2019 | -1.513M |
| December 31, 2018 | -1.798M |
| December 31, 2017 | -0.5837M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Silence Therapeutics Plc | -62.27M |
| Biodexa Pharmaceuticals Plc | -7.268M |
| NuCana Plc | -9.377M |
| Mereo BioPharma Group Plc | -31.04M |
| Compass Pathways Plc | -157.61M |